cholesterol

The Chief Pharmaceutical Inspector issued two decisions to ban the introduction of two drugs to the Polish market: Atorvastatin Medical Valley (40 mg) and Adnamil (300 mg). The first of them is used for high cholesterol levels, and the second for kidney stones.